The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
| Main Authors: | , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2008
|
| _version_ | 1797095750188924928 |
|---|---|
| author | Reder, A Ebers, G Goodin, D Li, D Traboulsee, A Beckman, K Konieczny, A |
| author_facet | Reder, A Ebers, G Goodin, D Li, D Traboulsee, A Beckman, K Konieczny, A |
| author_sort | Reder, A |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T04:32:22Z |
| format | Conference item |
| id | oxford-uuid:cec0ee03-a100-4bd9-abed-0a1844f7a02a |
| institution | University of Oxford |
| last_indexed | 2024-03-07T04:32:22Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:cec0ee03-a100-4bd9-abed-0a1844f7a02a2022-03-27T07:37:51ZThe interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomesConference itemhttp://purl.org/coar/resource_type/c_5794uuid:cec0ee03-a100-4bd9-abed-0a1844f7a02aSymplectic Elements at Oxford2008Reder, AEbers, GGoodin, DLi, DTraboulsee, ABeckman, KKonieczny, A |
| spellingShingle | Reder, A Ebers, G Goodin, D Li, D Traboulsee, A Beckman, K Konieczny, A The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes |
| title | The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes |
| title_full | The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes |
| title_fullStr | The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes |
| title_full_unstemmed | The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes |
| title_short | The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes |
| title_sort | interferon beta 1b 16 year long term follow up study neutralizing antibodies and clinical outcomes |
| work_keys_str_mv | AT redera theinterferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT ebersg theinterferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT goodind theinterferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT lid theinterferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT traboulseea theinterferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT beckmank theinterferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT koniecznya theinterferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT redera interferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT ebersg interferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT goodind interferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT lid interferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT traboulseea interferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT beckmank interferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes AT koniecznya interferonbeta1b16yearlongtermfollowupstudyneutralizingantibodiesandclinicaloutcomes |